(Mount Laurel, NJ; July 10, 2012) – CRI Lifetree opened a new state-of-the-art, early stage research facility in Marlton, N.J. The new site raises the company’s total bed count to 250 and adds capacity to conduct complex clinical trials.
CRI Lifetree, a leader in specialized early stage research focused in pain, human abuse liability, psychiatry, neurology and diabetes, announced its new location to the drug development industry at the 2012 Drug Information Association (DIA) Annual Meeting held June 24-28 in Philadelphia.
“Because our facility is so close to Philadelphia, DIA gave us the opportunity to show many clients the site firsthand. The feedback was overwhelmingly positive!” noted Larry Brownstein, CRI Lifetree’s head of corporate development.
Brownstein added, “The recent visitors were pleased to see we have expanded our research space with this new, 60-bed, purpose-built facility.”
The additional bed space and added capabilities for conducting complex neurology, pediatrics and normal healthy patient studies comes at a time of considerable need for the industry. Other facility features include six beds dedicated to first-in-human studies. This space has an observation area to allow clinicians and sponsors the access needed. The new center also has separate areas for elderly and pediatric populations. The 21,000-square-foot building adds to CRI Lifetree’s two other facilities in Philadelphia and Salt Lake City.
CRI Lifetree, formerly CRI Worldwide and Lifetree Clinical Research®, is a leader in specialized, multitherapeutic inpatient and outpatient early stage research.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.